Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Reshaping a therapeutic CD4 antibody.

S D Gorman1, M R Clark, E G Routledge

  • 1Department of Pathology, University of Cambridge, United Kingdom.

Proceedings of the National Academy of Sciences of the United States of America
|May 15, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transplantation tolerance: the big picture. Where do we stand, where should we go?

Clinical and experimental immunology·2017
Same author

Remission Induction in Patients with Lymphoid Malignancies Using Unconjugated CAMPATH-1 Monoclonal Antibodies.

Leukemia & lymphoma·2016
Same author

Limiting dilution analysis of the cells of immune system I. The clonal basis of the immune response.

Immunology today·2014
Same author

Limiting dilution analysis of cells of the immune system II: What can be learnt?

Immunology today·2014
Same author

Advantages of rat monoclonal antibodies.

Immunology today·2014
Same author

An oxidation-labile traceless linker for solid-phase synthesis.

Angewandte Chemie (International ed. in English)·2014
Same journal

Chemotactic self-organization captures the dynamics of mammalian hair follicle patterning.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same journal

Tomographic imaging of superconducting order using particle-hole interference.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same journal

Inhibitory potential of autologous neutralizing antibodies sets quantitative limits on the rebound-competent HIV-1 reservoir.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same journal

Inferring epidemiological parameters under an infectious phylogeography model with visitor dynamics.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same journal

Analytical modeling for suction cup designs for skin-interfaced wearable devices.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same journal

Improving cell-free metabolism through direct integration of artificial respiratory chains.

Proceedings of the National Academy of Sciences of the United States of America·2026
See all related articles

Researchers reshaped a rat antibody targeting human CD4 cells to manage autoimmune diseases and prevent organ transplant rejection. The KOL-based reshaped antibody showed only a slight decrease in binding effectiveness, making it a promising therapeutic candidate.

Area of Science:

  • Immunology
  • Biotechnology
  • Transplantation Science

Background:

  • The immunosuppressive rat antibody Campath-9 targets human CD4+ cells.
  • Campath-9 has potential applications in managing autoimmune diseases and preventing graft rejection.
  • Antibody engineering aims to improve therapeutic efficacy and reduce immunogenicity.

Purpose of the Study:

  • To reshape a rat anti-CD4 antibody (Campath-9) into a humanized form for improved therapeutic use.
  • To evaluate the binding avidity of reshaped antibodies with different human framework sequences.
  • To assess the feasibility of using in vitro mutagenesis for antibody framework grafting.

Main Methods:

  • Production of two reshaped forms of the anti-CD4 antibody using human myeloma protein frameworks (KOL and NEW).

Related Experiment Videos

  • Comparison of the avidity of reshaped antibodies against a chimeric anti-CD4 antibody.
  • Utilizing in vitro mutagenesis for grafting human framework sequences onto the rodent variable region.

    • Main Results:

    • The KOL-based reshaped antibody exhibited only a minor reduction in avidity compared to the chimeric form.
    • The NEW-based reshaped antibody demonstrated significantly poor avidity.
    • Successful reshaping to the KOL framework was achieved through human framework grafting and in vitro mutagenesis.

    Conclusions:

    • The KOL-based reshaped anti-CD4 antibody retains significant binding avidity, indicating its potential for therapeutic applications.
    • The NEW-based framework resulted in poor antibody avidity, suggesting limitations for this specific humanization approach.
    • Antibody framework grafting using in vitro mutagenesis is an effective strategy for developing humanized immunosuppressive antibodies.